Mycothiazole and its synthetic derivative target the mitochondria’s electron transport chain and show targeted toxicity against human cancer cells as well as anti-aging properties in worms.
USC Viterbi biomedical engineers have designed a protein that targets and disables tumor cells’ defenses while marking cancer cells for death.
Mathematician Paul Newton will use the prestigious fellowship to investigate cancer models; composer Nicolás Lell Benavides will complete several musical works.
A first-of-its-kind clinical trial from Keck Medicine of USC will investigate if immunotherapy administered at home can achieve the same outcomes as in-clinic therapy.
Researchers from disparate disciplines at USC, CHLA, Cedars-Sinai and Stanford University join to find solutions to cancer.
The recognition comes from The Leapfrog Group, a respected national hospital watchdog organization.
A study led by the Keck School of Medicine of USC found that third-generation Mexican Americans are 66% more likely to get liver cancer than the first generation.
Various PFAS and phenols were linked with higher rates of previous melanoma, ovarian cancer and uterine cancer diagnoses, according to a study co-led by the Keck School of Medicine of USC.
The blood test may distinguish between cancerous and benign pelvic masses with up to 91% accuracy, surpassing other commercially available tests.
The new Ralph Lauren Center for Cancer Prevention will aim to reduce cancer disparities in underserved communities in Los Angeles and surrounding areas.
